Aethlon Medical Stock Analysis

AEMD Stock  USD 1.45  0.06  3.97%   
Aethlon Medical is undervalued with Real Value of 17.31 and Target Price of 65.0. The main objective of Aethlon Medical stock analysis is to determine its intrinsic value, which is an estimate of what Aethlon Medical is worth, separate from its market price. There are two main types of Aethlon Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Aethlon Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Aethlon Medical's stock to identify patterns and trends that may indicate its future price movements.
The Aethlon Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Aethlon Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Aethlon Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Aethlon Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Aethlon Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aethlon Medical recorded a loss per share of 5.01. The entity last dividend was issued on the 15th of October 2019. The firm had 1:10 split on the 5th of October 2023. Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. For more info on Aethlon Medical please contact James Joyce at 619 941 0360 or go to https://www.aethlonmedical.com.

Aethlon Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aethlon Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aethlon Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aethlon Medical generated a negative expected return over the last 90 days
Aethlon Medical may become a speculative penny stock
Aethlon Medical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 574.25 K. Net Loss for the year was (12.03 M) with profit before overhead, payroll, taxes, and interest of 574.25 K.
Aethlon Medical currently holds about 14.92 M in cash with (10.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65.
Aethlon Medical has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Disposition of 2389 shares by Charles Fisher of Aethlon Medical at 1.35 subject to Rule 16b-3

Aethlon Medical Upcoming and Recent Events

Earnings reports are used by Aethlon Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aethlon Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of February 2024
Upcoming Quarterly Report
View
26th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of June 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

Aethlon Largest EPS Surprises

Earnings surprises can significantly impact Aethlon Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-11-09
2021-09-30-0.15-0.130.0213 
2023-06-28
2023-03-31-0.13-0.10.0323 
2022-11-14
2022-09-30-0.21-0.180.0314 
View All Earnings Estimates

Aethlon Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aethlon Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aethlon Medical backward and forwards among themselves. Aethlon Medical's institutional investor refers to the entity that pools money to purchase Aethlon Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bartlett & Co Wealth Management Llc2023-12-31
26.0
Susquehanna International Group, Llp2023-09-30
0.0
Larson Financial Group, Llc2023-09-30
0.0
Mercer Global Advisors Inc.2023-09-30
0.0
Virtu Financial Llc2023-09-30
0.0
Vanguard Group Inc2023-12-31
21.2 K
Geode Capital Management, Llc2023-12-31
20.3 K
Blackrock Inc2023-12-31
7.3 K
Group One Trading, Lp2023-12-31
1.3 K
Tower Research Capital Llc2023-12-31
1.1 K
Advisor Group Holdings, Inc.2023-12-31
299
Note, although Aethlon Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aethlon Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aethlon Medical's market, we take the total number of its shares issued and multiply it by Aethlon Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Aethlon Profitablity

Aethlon Medical's profitability indicators refer to fundamental financial ratios that showcase Aethlon Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Aethlon Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aethlon Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aethlon Medical's profitability requires more research than a typical breakdown of Aethlon Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(7.36)(7.73)
Return On Capital Employed(0.86)(0.81)
Return On Assets(7.36)(7.73)
Return On Equity(10.93)(10.38)

Management Efficiency

Aethlon Medical has return on total asset (ROA) of (0.4716) % which means that it has lost $0.4716 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9843) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical's management efficiency ratios could be used to measure how well Aethlon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of April 16, 2024, Return On Tangible Assets is expected to decline to -7.73. The current year's Return On Capital Employed is expected to grow to -0.81. At present, Aethlon Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 18.2 M, whereas Intangible Assets are forecasted to decline to 1,411.
Last ReportedProjected for Next Year
Book Value Per Share 6.60  6.93 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 6.60  6.93 
Enterprise Value Over EBITDA 0.42  0.44 
Price Book Value Ratio 0.47  0.49 
Enterprise Value Multiple 0.42  0.44 
Price Fair Value 0.47  0.49 
Enterprise Value-6.3 M-6 M
The analysis of Aethlon Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Aethlon Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Aethlon Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.936

Technical Drivers

As of the 16th of April 2024, Aethlon Medical shows the Mean Deviation of 1.79, standard deviation of 2.3, and Risk Adjusted Performance of (0.10). Aethlon Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for thirteen technical drivers for Aethlon Medical, which can be compared to its peers. Please confirm Aethlon Medical standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Aethlon Medical is priced correctly, providing market reflects its regular price of 1.45 per share. Please also double-check Aethlon Medical jensen alpha, which is currently at (0.39) to validate the company can sustain itself at a future point.

Aethlon Medical Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Aethlon Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Aethlon Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Aethlon Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aethlon Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aethlon Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aethlon Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aethlon Medical Predictive Daily Indicators

Aethlon Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aethlon Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Aethlon Medical Forecast Models

Aethlon Medical's time-series forecasting models are one of many Aethlon Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aethlon Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Aethlon Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aethlon Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aethlon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aethlon Medical. By using and applying Aethlon Stock analysis, traders can create a robust methodology for identifying Aethlon entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(18.85)(19.80)
Operating Profit Margin(23.83)(25.02)
Net Loss(286.73)(272.40)
Gross Profit Margin-8.9 K-8.5 K

Current Aethlon Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aethlon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aethlon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
65.0Buy2Odds
Aethlon Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Aethlon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aethlon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aethlon Medical, talking to its executives and customers, or listening to Aethlon conference calls.
Aethlon Analyst Advice Details

Aethlon Stock Analysis Indicators

Aethlon Medical stock analysis indicators help investors evaluate how Aethlon Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aethlon Medical shares will generate the highest return on investment. By understating and applying Aethlon Medical stock analysis, traders can identify Aethlon Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow17.2 M
Common Stock Shares Outstanding2.1 M
Total Stockholder Equity15.1 M
Total Cashflows From Investing Activities-943.1 K
Property Plant And Equipment Net2.3 M
Cash And Short Term Investments14.5 M
Cash14.5 M
Accounts Payable432.9 K
Net Debt-13.3 M
50 Day M A1.706
Total Current Liabilities1.5 M
Other Operating Expenses12.5 M
Non Current Assets Total2.4 M
Forward Price Earnings0.2102
Non Currrent Assets Other120.8 K
Stock Based Compensation1.1 M
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Aethlon Stock analysis

When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.01)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.47)
Return On Equity
(0.98)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.